This literature review evaluates the impact of restricted access to atypical antipsychotic drugs in individuals with schizophrenia or bipolar disorder.
Fred Grossman, MD, PhD
Advertisement
Articles by Fred Grossman, MD, PhD
Advertisement
Latest Updated Articles
- Review of Outcomes Associated With Restricted Access to Atypical Antipsychotics
Published: June 14th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
2
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
5
